Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL - HSA Drug Approval Details

Approvals/HSA/RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL

Approved

THERAPEUTIC

RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL

Shandong Luye Pharmaceutical Co., Ltd.Shandong Luye Pharmaceutical Co., Ltd. (Diluent)🇸🇬 Health Sciences Authority

Approval Date: Feb 20, 2025
Approval ID: f7efc8820b855567
Company: Shandong Luye Pharmaceutical Co., Ltd.Shandong Luye Pharmaceutical Co., Ltd. (Diluent)
Type: Therapeutic

Approval Details

Approval Id: f7efc8820b855567
Drug Name: RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL
Product Name: RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL
Approval Number: SIN17183P
Approval Date: 2025-02-20
Registrant: LUYE PHARMA (SINGAPORE) PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route Of Administration: INTRAMUSCULAR
Atc Code: N05AX08
Pharma Manufacturer Name: LUYE PHARMA (SINGAPORE) PTE. LTD.
Company Detail Path: /organization/b01250f9498c5429/luye-pharma-singapore-pte-ltd

Active Ingredients

Risperidone

25mg/vial

Risperidone

25mg/vial

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 20, 2025

Approval ID

f7efc8820b855567

Type

Therapeutic

Back to HSA Approvals